Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This clinical trial studies how well and how easy it is to use a device called Flyte in improving problems with bladder control (urinary incontinence) among endometrial and cervical cancer survivors who have undergone radiation therapy. Urinary incontinence is common after pelvic radiation therapy and can affect daily life and well-being. Access to in-person pelvic floor physical therapy can be limited. The Flyte device is designed for in-home use to deliver a series of mechanical vibrations at a specific frequency while the pelvic floor muscles are contracting and relaxing (i.e., normal, guided Kegel exercises). This treatment is called mechanotherapy. The Flyte device may improve urinary incontinence symptoms, as well as overall quality of life among endometrial and cervical cancer survivors who have undergone radiation therapy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Kobieta po radioterapii miednicy z powodu raka szyjki macicy lub endometrium (co najmniej 3 miesiące temu)
- •Wiek 21 lat lub więcej
- •Rozpoznanie problemów z kontrolą moczu lub nadreaktywnym pęcherzem
- •Zdolność do ćwiczenia mięśni dna miednicy bez bólu
- •Dostęp do internetu i smartfona z systemem iOS lub Android
- •Możliwość uczestniczenia w obserwacji w ramach badania
✗ Disqualifies
- •Radioterapia lub operacja chirurgiczna w ciągu ostatnich 3 miesięcy
- •Bieżące leczenie przeciwnowotworowe (chemioterapia)
- •Spodziewana długość życia poniżej 6 miesięcy
- •Niemożność wprowadzenia urządzenia waginalnego lub ból podczas wprowadzania
- •Podejrzenie przewodu przetokowego między pęcherzem a pochwą
- •Zaburzenia poznawcze lub neurologiczne wpływające na udział w badaniu
- •Aktywny proces zakaźny lub krew w moczu
Simplified criteria — AI translation
Trial details
- Minimum age
- 21 Years
- Last updated (source)
- August 31, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Mayo Clinic in Rochester
Rochester, United States
Trial contact
Clinical Trials Referral Office
Kelly Gunderson
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.